Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.
about
Prophylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemiaProphylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemiaL-asparaginase in the treatment of patients with acute lymphoblastic leukemiaBest Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on AsparaginaseDrug-induced hematologic syndromesAcute thrombosis in superior mesenteric artery as first symptom in a AML patientThromboembolic and bleeding complications in acute leukemia.Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trialCentral Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell TransplantationA minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort studyDo children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validationApproach to chemotherapy-associated thrombosis.Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelaeRadiologic Image of a Child with Leukemia Who Developed Sepsis and Fulminant Thrombosis during Induction TherapyAsparaginase-associated toxicity in children with acute lymphoblastic leukemia.Thrombosis and acute lymphoblastic leukaemia.Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survivalVenous Thromboembolism in Children with Cancer and Blood Disorders.Venous thromboembolism in children with cancer - a population-based cohort study.Treatment of thromboembolism in cancer patients.Personal practice: how we manage the risk of bleeding and thrombosis in children and young adults with acute lymphoblastic leukaemia.Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel.The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.Management of thrombotic complications in acute lymphoblastic leukemia.Thrombosis in pediatric cancer: identifying the risk factors to improve care.Cerebral Thrombotic Complications Related to l-Asparaginase Treatment for Acute Lymphoblastic Leukemia: Retrospective Review of 10 Cases.L-asparaginase and venous thromboembolism in acute lymphocytic leukemiaCell-based laboratory evaluation of coagulation activation by antineoplastic drugs for the treatment of lymphoid tumors.Incidence and characteristics of venous thrombotic events in pediatric cancer patients: A 20-year experience in the Maritimes, Canada.Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients.Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review.Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia.Adverse effects of pegaspargase in pediatric patients receiving doses greater than 3,750 IU.
P2860
Q24201128-AA8C7F58-56E2-4EB0-A6DA-694C4D89D11DQ26472077-D272E427-9694-460D-BEA8-B11DF3C48F38Q26738640-78F52ACB-3E6A-4E14-B509-FC6208196B04Q26784116-8700CB87-62C5-42C5-8312-9B572F585882Q33387312-AE620049-A07C-4971-8258-122E1741A155Q33389351-25A55C58-6499-482C-AEBE-A22D8151F39DQ33392897-93988B42-8036-4C7A-B146-E9D646153AAFQ33557148-40CB4590-74E5-48A5-92A9-8A8F1C427571Q33655100-184F7F92-5939-4E13-AA05-D08769FDD389Q33679931-E83DFEA8-868B-4EFA-84EC-DA41FA43BDCAQ33775222-62CEC42B-566B-406D-8582-0DCBEF3804CBQ33931714-DC212FF1-E4CA-4273-93AA-69B14DC85564Q34352879-B1D994F0-2C1F-4F52-A0B3-AC283AE8D9EFQ35758669-8F4E8D59-DB02-4E3A-850A-DFD0DD6BF576Q35944683-392A27C5-41C7-4E7D-B4CC-3168D1F7FAEDQ36304793-615BDB85-5ADC-4F06-BD8D-D010FB90F857Q36661874-0A759CE7-1AFE-447A-B924-A96120732F83Q36722790-13DF6732-87D7-4348-99B0-77F2B1418EAEQ36762608-9E01EB7A-458E-48F9-97E6-B219B3070947Q36869374-08A86094-F32B-46E9-8D4F-263AC1B17C8FQ37169120-BF77133B-5D3B-4FCB-915A-CAF0CA02C867Q37625771-E80120B5-E73B-4A2F-9855-43DF0CA9B369Q37672276-4F271C2D-6B8D-4657-A86B-F16D6CF0251FQ37773994-34F489CB-708F-4FA5-85E7-4DD6A2FCF0BFQ37830722-4A74A642-9923-4091-99B9-620868244052Q37914185-7636D44C-483E-42FB-9F74-32C61F835EACQ38055656-7B06357F-84C3-48D8-8669-BDCB4D082704Q38126391-2419EB2E-744B-4A76-876F-00B9C8E8CD9DQ38152512-0A6C3550-FE68-44F2-8ABD-4FD90370BAF2Q38360789-1625CC03-3619-497C-8A04-B0DD74DCE8BBQ38566744-54ABE4CC-9EAF-4F99-8525-9D809AEC9D15Q38752911-77E0178D-FF89-4C9A-963F-3F1DC24A8D2BQ38767435-CAC9B21B-7DA8-4CB5-BE16-F331368B08CBQ38779952-FD6BB2DA-F862-4290-9271-D67C98CF1E26Q38927735-E57C8220-35E0-45CF-A3F0-06616DDFB2F6Q38984772-030D36B5-6164-4005-A769-FE98C6A33F9BQ38985825-244615CC-1E06-4FCE-935C-20B468F56145Q39165240-A3A44C0A-D309-471D-B44F-773456132DA6Q39194553-3E6E2776-2C73-42CC-BE2C-EE98D0949931Q39258365-99D13BC9-4FF8-4671-A15D-5764227F4DF6
P2860
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Thrombotic complications in ch ...... ising 1752 pediatric patients.
@en
type
label
Thrombotic complications in ch ...... ising 1752 pediatric patients.
@en
prefLabel
Thrombotic complications in ch ...... ising 1752 pediatric patients.
@en
P2093
P50
P1433
P1476
Thrombotic complications in ch ...... ising 1752 pediatric patients.
@en
P2093
Augusto Di Castelnuovo
Guglielmo Mariani
Sergio Storti
Vanesa Caruso
P304
P356
10.1182/BLOOD-2006-04-015511
P407
P577
2006-06-27T00:00:00Z